Literature DB >> 10395639

Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells.

H Ozaki1, K Ishii, H Horiuchi, H Arai, T Kawamoto, K Okawa, A Iwamatsu, T Kita.   

Abstract

Proinflammatory cytokines such as TNF-alpha and IFN-gamma induce cell adhesion molecules in endothelial cells and promote transmigration of leukocytes across endothelial cells. However, when those two were administered together, leukocyte transmigration paradoxically decreased. We cloned a human and bovine homologue of the junctional adhesion molecule (JAM), a novel molecule at the tight junction, and examined the effects of proinflammatory cytokines on JAM in HUVECs. The combined treatment of TNF-alpha plus IFN-gamma caused a disappearance of JAM from intercellular junctions. However, flow cytometry, cell ELISA, and subcellular fractionation analysis demonstrated that the amount of JAM was not reduced. This suggested that JAM changed its distribution in response to proinflammatory cytokines. This redistribution of JAM might be involved in a decrease in transendothelial migration of leukocytes at inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395639

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif.

Authors:  D Kostrewa; M Brockhaus; A D'Arcy; G E Dale; P Nelboeck; G Schmid; F Mueller; G Bazzoni; E Dejana; T Bartfai; F K Winkler; M Hennig
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

2.  JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration.

Authors:  Ke Zen; Brian A Babbin; Yuan Liu; John B Whelan; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

3.  Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.

Authors:  Theresa Vincent; Ralf F Pettersson; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.

Authors:  George T Mercier; Jacquelyn A Campbell; James D Chappell; Thilo Stehle; Terence S Dermody; Michael A Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

Review 5.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

6.  Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion.

Authors:  Chrystelle Lamagna; Paolo Meda; Guillaume Mandicourt; James Brown; Robert J C Gilbert; E Yvonne Jones; Friedemann Kiefer; Pilar Ruga; Beat A Imhof; Michel Aurrand-Lions
Journal:  Mol Biol Cell       Date:  2005-08-10       Impact factor: 4.138

Review 7.  TAM receptor deficiency affects adult hippocampal neurogenesis.

Authors:  Rui Ji; Lingbin Meng; Qiutang Li; Qingxian Lu
Journal:  Metab Brain Dis       Date:  2014-12-10       Impact factor: 3.584

Review 8.  Cytokine regulation of tight junctions.

Authors:  Christopher T Capaldo; Asma Nusrat
Journal:  Biochim Biophys Acta       Date:  2008-10-08

9.  Identification of tumor associated single-chain Fv by panning and screening antibody phage library using tumor cells.

Authors:  Yong-Zhan Nie; Feng-Tian He; Zhi-Kui Li; Kai-Chun Wu; Yun-Xin Cao; Bao-Jun Chen; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 10.  Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling.

Authors:  Eric A Severson; Charles A Parkos
Journal:  Curr Opin Cell Biol       Date:  2009-07-14       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.